Latest News and Press Releases

YHTIÖKOKOUSKUTSU Takoma Oyj:n varsinainen yhtiökokous pidetään tiistaina joulukuun 18. päivänä 2007 alkaen kello 9.00 Tampereen...

Nokian Tyres plc Stock Exchange Announcement 29.11.2007 10.00 am FINANCIAL REPORTING SCHEDULE FOR YEAR 2008 During the year 2008, Nokian Tyres plc will publish the year 2007 Financial Statement...

Pressmeddelande 29 november 2007 Boindex sjönk till 109,7 tredje kvartalet - Husköpkraften relativt stabil i riket som helhet Swedbank publicerar idag Boindex för tredje kvartalet 2007. Boindex, som...

YHTIÖKOKOUSKUTSU Panostaja Oyj:n varsinainen yhtiökokous pidetään tiistaina joulukuun 18. päivänä 2007 alkaen kello 10.00 Tampereen...

Hermed fremsendes medddelelse om tegning af andele i afdeling Danske Aktier. ...

Pressmeddelande Morphic Technologies AB (publ) Karlskoga 2007-11-28 Morphic förvärvar bränslecellstillverkaren Arcotronics Fuel Cells och genomför riktad nyemission Morphic har träffat avtal om...

Nykredit knytter med nedenstående endelige vilkår 3 nye obligationsserier til ”Prospekt for udbud af særligt dækkede obligationer i Nykredit Realkredit A/S, kapitalcenter E”: 1. ”Endelige vilkår...

29 November 2007 - StatoilHydro has today, on behalf of the Morvin license group, awarded Aker Kvaerner a contract for the engineering, procurement and construction (EPC) of a complete subsea...

Dedicare störst i Sverige på uthyrning av sjuksköterskor Dedicare, ett bolag i Pooliakoncernen, är nu störst i Sverige på sjuksköterskebemanning. Efter flera år av stadig tillväxt har bolaget nått...

XPonCards innehav av aktier i ACSC uppgår efter den förlängda acceptperiodens slut till 96,6 procent. XPonCard Group AB (publ) ("XPonCard") och All Cards Service Center - ACSC - AB (publ.) ("ACSC")...

Following the close of the extended acceptance period, XPonCard's holding of ACSC shares amounts to 96,6 %. XPonCard Group AB (publ) ("XPonCard") and All Cards Service Center - ACSC - AB (publ)...

Ny valberedningen i Teligent AB utgörs av Hasse Iwarsson, Kistefos, Olle Isberg, Visionalis, Caroline af Ugglas, Skandia samt Jonas Fredriksson, Öhman IT-Fond. I enlighet med beslut på årsstämman den...

OMX bekendtgør hermed modtagelse af tilbudsdokument vedr. købstilbud til aktionærerne i Spæncom A/S, jf. vedhæftede fil. ...

OMX bekendtgør hermed modtagelse af tilbudsannonce vedr. købstilbud til aktionærerne i Spæncom A/S, jf. vedhæftede fil ...

OMIEN OSAKKEIDEN HANKINTA 28.11.2007 Konecranes Oyj ILMOITUS 28.11.2007 OMIEN...

Correction:Notifications on transactions concluded by managers of the companies ...

Attached please find the full report as PDF file. Dampskibsselskabet ”NORDEN” A/S _______________________________________________________________________________ OMX Nordic Exchange...

For release content, please refer to the attachment....

29 November 2007 - StatoilHydro has today, on behalf of the Morvin license group, awarded Aker Kvaerner a contract for the engineering, procurement and construction (EPC) of a complete subsea...

Den indre værdi af KlimaInvest A/S er d.d. opgjort til 102,70 kr. pr. aktie baseret på seneste lukkekurser. I opgørelsen er egenkapitalen baseret på den aktuelle kursværdi af selskabets portefølje...

Indre værdi den 29. november 2007: 98,34 ...

Bavarian Nordic reports the successful completion of a large, placebo-controlled Phase II trial in 745 healthy subjects who received either one or two doses of IMVAMUNE® third-generation smallpox...

Bavarian Nordic rapporterer om en succesrig afslutning på et større placebo-kontrolleret fase II studie. 745 raske forsøgspersoner som modtog enten en eller to doser IMVAMUNE®...

Drillcon rapportdatum 2008 Drillcon AB (publ), listat på First North, meddelar följande datum för rapporter under 2008. Bokslutskommuniké: 14 februari 2008 Kvartalsrapporter: Q1, 8 maj 2008 ...

IRVINE, Calif., Nov. 29, 2007 (PRIME NEWSWIRE) -- "An estimate of $2 billion worth of gold (at $650 an ounce) has fostered obvious interest in a property known as the La Planada Gold Project in...

• Fastighetsintäkterna uppgick till 273,9 mkr (139,8). • Periodens resultat uppgick till 148,0 mkr (194,0), vilket motsvarar 9,05 kronor per aktie (15,25) före och efter utspädning. • Av periodens...

Bavarian Nordic reports the successful completion of a large, placebo-controlled Phase II trial in 745 healthy subjects who received either one or two doses of IMVAMUNE® third-generation smallpox...

Bavarian Nordic rapporterer om en succesrig afslutning på et større placebo-kontrolleret fase II studie. 745 raske forsøgspersoner som modtog enten en eller to doser IMVAMUNE® tredjegenerations...

Bringwell förvärvar finska Vitacom Pharma OY - öppnar upp en helt ny marknad Genom förvärvet av Vitacom Pharma OY uppnår Bringwell målet om lokal närvaro på samtliga nordiska marknader med...

Limarko laivininkystės kompanija AB (LLK) announces revised plans of 2007 results. Profit before taxes plan is increased from LTL 10 - 12 million (EUR 2.9 - 3.5 million) to LTL 18 million (EUR 5.2...

AS Eston Ehitus, a subsidiary in which AS Eesti Ehitus has acquired a 52% interest and Win Markets OÜ signed an agreement for AS Eston Ehitus to build new parking house situated at Lai street 7,...

Notabene.net A/S' interim accounts for Quarter 1 2007/2008 show a profit in the amount of DKK 8,568 million before tax as against the result of Quarter 1 of the financial year 2006/2007 in the...

Jersey, Channel Islands--(Marketwire - November 29, 2007) - RANDGOLD RESOURCES LIMITED Incorporated in Jersey, Channel Islands Reg. No. 62686 LSE Trading Symbol: RRS Nasdaq Trading Symbol:...

City Service AB has signed a general co-operation agreement with Middle Europe Investments Baltija UAB. The contract aims to establish City Service AB as the only provider of facilities management,...

Componenta's share capital increase due to conversion of convertible capital notes and new shares to be listed 8 note units of Componenta Corporation's convertible capital notes 2005 have been...

Componentan osakepääoman korotus vaihdettavien pääomalainojen lainaosuuksien vaihdon perusteella ja uusien osakkeiden ottaminen pörssilistalle Componenta Oyj:n vuonna 2005 liikkeeseen laskemasta...

Mechelen, België en Bethesda, Maryland, VS; 29 november 2007 - Galapagos NV (Euronext & LSE: GLPG) en Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), de aan de Cystic Fibrosis Foundation...

Mechelen, Belgium and Bethesda, Maryland, USA; 29 November 2007 - Galapagos NV (Euronext & LSE: GLPG) and Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the non-profit affiliate of the...

Amsterdam, November 29, 2007 -  Akzo Nobel N.V. (Akzo Nobel) has announced a number of proposed changes to its Board of Management and Supervisory Board in advance of January's expected...

SEB's Financial Officers' survey, addressed to around 50 of Sweden's largest companies, shows that one in three financial officers is now worried about a potential fall in demand. At the same time the...

SEB:s finanschefsenkät, riktad till Sveriges drygt 50 största företag, avslöjar att en av tre finanschefer nu är oroad för fallande efterfrågan. Samtidigt visar finanscheferna på motståndskraft, och...

ETTEPLAN REVISES INTERNATIONAL OPERATIONS Etteplan revises its' international business operations model. The actions to be taken aim to better customer...

-------------------------------------------------------------------------------- | Annex of the Rules of the notifications on the transactions in issuer's | | securities concluded by managers...

The Q3/2007 interim report of Olympic Entertainment Group AS is available on the Internet homepage of the Tallinn Stock Exchange at http://www.baltic.omxgroup.com/en/market/reports/main...

La Food and Drug Administration (FDA) américaine a accepté la demande de mise sur le marché (NDA) de Vimpat(TM) (lacosamide) en tant que thérapie adjuvante des crises d'épilepsie partielle chez les...

U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for the use of Vimpat(TM) (lacosamide) in the treatment of adults with diabetic neuropathic pain....

De Amerikaanse Food and Drug Administration (FDA) heeft de New Drug Application (NDA) voor het gebruik van Vimpat(TM) (lacosamide) voor de behandeling van epilepsie aanvallen met partieel begin bij...

De Amerikaanse Food and Drug Administration (FDA) heeft de New Drug Application (NDA) voor het gebruik van Vimpat(TM) (lacosamide) voor de behandeling van diabetische neuropathische pijn aanvaard....

U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for the use of Vimpat(TM) (lacosamide) as adjunctive therapy in the treatment of partial onset seizures...

La Food and Drug Administration (FDA) américaine a accepté la demande de mise sur le marché (NDA) pour l'utilisation de Vimpat(TM) (lacosamide) dans le traitement des douleurs neuropathiques...